- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about AVIR
Recent news which mentions AVIR
From InvestorPlace
Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Boosts FY21 Guidance
October 19, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 19, 2021
From Benzinga
Why Are Atea Pharmaceuticals Shares Plunging Today?
October 19, 2021
From Benzinga
3 Stocks to Consider if the October Stock Market Sell-Off Worsens
October 17, 2021
From Motley Fool
3 COVID-19 Pill Stocks to Watch
October 16, 2021
From Motley Fool
The success of Merck’s antiviral—and other COVID-19 pills in development—may depend on how quickly people start taking them
October 14, 2021
From MarketWatch
3 COVID Stocks That Can Turn $1,000 Into $10,000
October 12, 2021
From Motley Fool
Molnupiravir? Not So Fast. What About Tollovir? — Here's Why You Should Know What That Means
October 12, 2021
From Benzinga
From Motley Fool
10 Health Care Stocks With Unusual Options Alerts In Today's Session
October 08, 2021
From Benzinga
From Motley Fool
Why Novavax Stock Plunged in September
October 06, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021
October 05, 2021
From Benzinga
Which COVID-19 Pill Stock Is the Best Buy?
October 05, 2021
From Motley Fool
2 Best Biotech Stocks to Buy In October
October 04, 2021
From Motley Fool
3 Stocks That Might Soar With Pills for COVID
October 03, 2021
From Motley Fool
Here Are the Leaders in the Race to Develop a COVID-19 Pill
October 03, 2021
From Motley Fool
Mid-Afternoon Market Update: Nasdaq Rises Over 100 Points; Biomerica Shares Spike Higher
October 01, 2021
From Benzinga
From MarketWatch
12 Health Care Stocks Moving In Friday's Intraday Session
October 01, 2021
From Benzinga
Mid-Day Market Update: Dow Surges 300 Points; Omeros Shares Plummet
October 01, 2021
From Benzinga
Why Atea Pharmaceutical Stock Is Ripping Higher Today
October 01, 2021
From Motley Fool
Mid-Morning Market Update: Markets Mostly Higher; ISM Manufacturing Index Rises In September
October 01, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 30, 2021
From Benzinga
48 Biggest Movers From Yesterday
September 21, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 20, 2021
From Benzinga
35 Stocks Moving In Monday's Mid-Day Session
September 20, 2021
From Benzinga
7 Biotech Stocks to Buy That Have Millionaire-Maker Potential
September 10, 2021
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.